Logo image of ALINS.PA

INTRASENSE SAS (ALINS.PA) Stock Price, Forecast & Analysis

Europe - Euronext Paris - EPA:ALINS - FR0011179886 - Common Stock

0.248 EUR
+0.02 (+8.77%)
Last: 1/14/2026, 7:00:00 PM

ALINS.PA Key Statistics, Chart & Performance

Key Statistics
Market Cap13.07M
Revenue(TTM)2.65M
Net Income(TTM)-6.48M
Shares52.72M
Float22.64M
52 Week High0.43
52 Week Low0.22
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.12
PEN/A
Fwd PEN/A
Earnings (Next)03-23
IPO2012-02-22
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
ALINS.PA short term performance overview.The bars show the price performance of ALINS.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10

ALINS.PA long term performance overview.The bars show the price performance of ALINS.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -10 -20 -30 -40

The current stock price of ALINS.PA is 0.248 EUR. In the past month the price increased by 1.64%. In the past year, price increased by 1.64%.

INTRASENSE SAS / ALINS Daily stock chart

ALINS.PA Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to ALINS.PA. When comparing the yearly performance of all stocks, ALINS.PA is a bad performer in the overall market: 81.68% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ALINS.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ALINS.PA. ALINS.PA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALINS.PA Financial Highlights

Over the last trailing twelve months ALINS.PA reported a non-GAAP Earnings per Share(EPS) of -0.12. The EPS decreased by -56.42% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -70.48%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-39.79%
Sales Q2Q%33.25%
EPS 1Y (TTM)-56.42%
Revenue 1Y (TTM)13.56%

ALINS.PA Forecast & Estimates

7 analysts have analysed ALINS.PA and the average price target is 0.24 EUR. This implies a price decrease of -1.29% is expected in the next year compared to the current price of 0.248.

For the next year, analysts expect an EPS growth of 37.5% and a revenue growth 71.49% for ALINS.PA


Analysts
Analysts40
Price Target0.24 (-3.23%)
EPS Next Y37.5%
Revenue Next Year71.49%

ALINS.PA Ownership

Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About ALINS.PA

Company Profile

ALINS logo image Intrasense SA engages in the design and development of advanced software solutions for viewing and analyzing of medical images. The company is headquartered in Montpellier, Occitanie and currently employs 76 full-time employees. The company went IPO on 2012-02-22. The Company’s activities are divided into three divisions: sales of software for viewing and analyzing medical images; development of peripheral solutions;and supply of services. Its product portfolio comprises the Myrian line products are integrated into existing medical devices, such as Cr, Ultra sound and Nuclear imagining. Myrian Solutions are used for reconstruction of images from the Computed tomography(CT) scan, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography scans, marketed under Myrian brand. The peripheral solutions provide materials for viewing digital images in the operating room, as well as various equipment, including printing servers and workstations, among others. The company offers also support, maintenance, as well as software rental and installation services for its products.

Company Info

INTRASENSE SAS

1231 Avenue du Mondial 98

Montpellier OCCITANIE FR

Employees: 76

ALINS Company Website

ALINS Investor Relations

Phone: 33467130130

INTRASENSE SAS / ALINS.PA FAQ

Can you describe the business of INTRASENSE SAS?

Intrasense SA engages in the design and development of advanced software solutions for viewing and analyzing of medical images. The company is headquartered in Montpellier, Occitanie and currently employs 76 full-time employees. The company went IPO on 2012-02-22. The Company’s activities are divided into three divisions: sales of software for viewing and analyzing medical images; development of peripheral solutions;and supply of services. Its product portfolio comprises the Myrian line products are integrated into existing medical devices, such as Cr, Ultra sound and Nuclear imagining. Myrian Solutions are used for reconstruction of images from the Computed tomography(CT) scan, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography scans, marketed under Myrian brand. The peripheral solutions provide materials for viewing digital images in the operating room, as well as various equipment, including printing servers and workstations, among others. The company offers also support, maintenance, as well as software rental and installation services for its products.


What is the current price of ALINS stock?

The current stock price of ALINS.PA is 0.248 EUR. The price increased by 8.77% in the last trading session.


Does ALINS stock pay dividends?

ALINS.PA does not pay a dividend.


What is the ChartMill rating of INTRASENSE SAS stock?

ALINS.PA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Where is INTRASENSE SAS (ALINS.PA) stock traded?

ALINS.PA stock is listed on the Euronext Paris exchange.


What is the market capitalization of ALINS stock?

INTRASENSE SAS (ALINS.PA) has a market capitalization of 13.07M EUR. This makes ALINS.PA a Nano Cap stock.